Literature DB >> 23852694

Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations.

Jette Primdahl1, Joan Clausen, Kim Hørslev-Petersen.   

Abstract

AIM: To investigate risk factors for the development of cardiovascular disease (CVD) and estimate the risk of cardiovascular death in rheumatoid arthritis (RA) patients in accordance with EULAR recommendations.
MATERIALS AND METHODS: Outpatients with RA ≤85 years of age from a Danish hospital were invited to participate. Patients' risk of cardiovascular death was calculated according to the SCORE system, based on total cholesterol/high-density lipoprotein (HDL) ratio, smoking habits, blood pressure, age and gender. The SCORE was adjusted based on disease duration, IgM-RF/anti-CCP positivity and the presence of extra-articular manifestations. Factors such as history of CVD, hypertension or diabetes mellitus (DM), fasting glucose, exercise habits, body mass index (BMI) and waist circumference were explored.
RESULTS: 836 patients participated; 71.5% women; mean (SD) age 64.3 years (12.0); 152 (19.1%) were already diagnosed with CVD and 74 (9.0%) with DM. Among the 644 patients without CVD or DM, 158 (24.5%) were smokers, 229 (35.8%) had a systolic blood pressure ≥140, 397 (65.6%) total cholesterol ≥5.0 mM/L, 326 (55.4%) low-density lipoprotein cholesterol ≥3.0 mM/L, 18 (4.0%) women and 19 (12.1%) men had a HDL-cholesterol level below 1.2/1.0 mM/L. BMI was >25 in 409 (63.8%). Waist circumference was above 80/94 cm in 297 (63.3%) of female and 111 (63.8%) of male patients, respectively, and 418 (64.9%) exercised ≤5 times a week. Among patients without DM, 14.3% had a fasting glucose ≥6.0 mmol/L. The SCORE was ≥5 in 122 (20.2%). They were referred to follow-up by their GP and community advice services.
CONCLUSIONS: Systematic screening revealed several risk factors that needed medical follow-up or support to initiate lifestyle changes.

Entities:  

Keywords:  Cardiovascular Disease; Epidemiology; Nursing; Rheumatoid Arthritis

Mesh:

Substances:

Year:  2013        PMID: 23852694     DOI: 10.1136/annrheumdis-2013-203682

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives.

Authors:  Christie M Bartels; Tonya J Roberts; Karen E Hansen; Elizabeth A Jacobs; Andrea Gilmore; Courtney Maxcy; Barbara J Bowers
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-04       Impact factor: 4.794

2.  Patient Perspectives on Smoking Cessation and Interventions in Rheumatology Clinics.

Authors:  Aimée Wattiaux; Brittany Bettendorf; Laura Block; Andrea Gilmore-Bykovskyi; Edmond Ramly; Megan E Piper; Ann Rosenthal; Jane Sadusky; Elizabeth Cox; Betty Chewning; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

3.  [Treatment of cardiovascular risk factors].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

4.  Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.

Authors:  Christoffer B Nissen; Kim Hørslev-Petersen; Jette Primdahl
Journal:  Rheumatol Int       Date:  2016-11-26       Impact factor: 2.631

Review 5.  Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.

Authors:  Ann M Chodara; Aimée Wattiaux; Christie M Bartels
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

6.  Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study.

Authors:  Irazú Contreras-Yáñez; Guillermo Guaracha-Basáñez; Virginia Pascual-Ramos
Journal:  Rheumatol Int       Date:  2019-10-12       Impact factor: 2.631

Review 7.  Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Rheumatology (Oxford)       Date:  2015-07-23       Impact factor: 7.580

8.  Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care.

Authors:  Christie M Bartels; Heather Johnson; Katya Voelker; Carolyn Thorpe; Patrick McBride; Elizabeth A Jacobs; Nancy Pandhi; Maureen Smith
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-09       Impact factor: 4.794

9.  Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.

Authors:  Kashif Jafri; Christie M Bartels; Daniel Shin; Joel M Gelfand; Alexis Ogdie
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-28       Impact factor: 4.794

10.  Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Kashif Jafri; Alexis Ogdie; Atif Qasim; Sarah L Patterson; Milena Gianfrancesco; Zara Izadi; Patricia Katz; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Clin Rheumatol       Date:  2017-10-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.